Approval · Notice of Compliance 13441 · 2012
VELCADE: Notice of Compliance 13441
Issued June 27, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13441
- Date
- June 27, 2012
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an altenrate manufacturing, packaging and testint site
- Therapeutic class
- Antineoplastic Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELCADE | Not yet assigned | — |
Medicinal ingredients
- BORTEZOMIB MANNITOL BORONIC ESTER 3.5 MG per VIAL